Impact of SGLT2 on Glucosuria in HNF1A-MODY

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

June 14, 2023

Study Completion Date

June 14, 2023

Conditions
Maturity-Onset Diabetes of the Young, Type 3Type 2 Diabetes
Interventions
OTHER

Hyperglycaemic clamp

Three-hour, three-step glucose clamp with plasma glucose targets 10, 14 and 18 mmol/l (each one hour)

DRUG

Placebo

Placebo comparator to empagliflozin

DRUG

Empagliflozin

Single-dose, 25 mg, two hours before clamp

Trial Locations (1)

2730

Steno Diabetes Center Copenhagen, Herlev

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER